Ripon Forum


Vol. 59, No. 4

View Print Edition

In this edition

At a time when spending in just about every area of the federal government is coming under intense scrutiny and review, the latest edition of The Ripon Forum examines the importance of investing in health research and why is it critical that the United States remain a global leader in that regard.

Is There Room in American Politics for the Don Bacons of the World?

Bacon’s success is thanks to strong relationships in his district and his brand as a centrist, opposing his party line just often enough to win over voters who otherwise prefer Democrats.

Today’s Trade War: Hype vs. Reality

In 2018, President Trump proclaimed trade wars “are good and easy to win.” Now, six months into the President’s latest trade war, the results have proven to be anything but.

Saving Can-Do: How to Revive the Spirit of America

Howard’s concern these days – and the focus for much of his latest book – has less to do with the DOGE wrecking ball that has been tearing through Washington than the question of what comes next.

Kelly Ayotte’s Six Month Report Card

It has been roughly six months since Governor Kelly Ayotte was sworn into the corner office in New Hampshire. While it is still obviously early in her term, she remains popular and enjoys a double digit favorability rating as a Republican in a purple state that was also won by Kamala Harris. Her achievements in […]

America First in Health Research

The U.S. should commit itself to making the most of that next generation of healthcare and maintain our position as the world’s premier leader in medical breakthroughs.

America’s Pharmaceutical Supply Chain is in Crisis

The United States should never be dependent on the Chinese Communist Party for antibiotics and essential medicines. But that’s exactly the dangerous position we are in today.

Vaccines Lead to Better Health and Greater Productivity

The creation, development, and deployment of vaccines – a U.S. federal priority since the 1960s – has been one of the greatest health care achievements in history.

The Cost of Chronic Disease

As of 2023, roughly 194 million American adults had at least one chronic condition, which cost our nation’s economy billions of dollars each year.

America the Overprescribed

The best way to prevent the downstream effects of overprescribing is to prevent it in the first place. That also means a concerted effort to prevent overdiagnosis.

The Future of AI in Health Care: Moving at the Speed of Trust

For modernization to truly take hold, and for the adoption of artificial intelligence to be systematic and widespread, we need greater confidence in its safety and effectiveness.

Should the Government Control Drug Prices? No…

Most favored nation would further devastate drug research.

Should the Government Control Drug Prices? Yes…

The key to effectively constraining spending on drugs without stifling innovation is regulating drug prices wisely, with the goal of having reductions in funding concentrated in innovations that have the most limited prospects of increasing value to patients.

Remembering Mike Castle

The Honorable Mike Castle, who was the sole representative of Delaware in the U.S. House of Representatives, passed away at the age of 86 on August 14, 2025.

Ripon Profile of Greg Murphy

Greg Murphy reflects on how his career as a doctor shapes his service as a Member of Congress.

The Future of AI in Health Care: Moving at the Speed of Trust

Lucy Orr-Ewing

Last month, the White House launched their AI Action Plan at an event entitled, “Winning the AI Race.”  The plan lays out a U.S. roadmap to establish global dominance reminiscent of preceding races in space exploration and nuclear weapons. 

This race, however, has a less obvious endpoint than putting a man on the moon.  Indeed, the point at which the winner will be declared is unclear. It will unlikely be marked by the development of a single breakthrough AI tool that becomes widely used across society. Instead, success will rest on building the robust, secure infrastructure that enables many AI innovations to flourish while ensuring trust in the technology through the quality of its outputs and the responsibility with which it is applied.

While many nations are advancing in this race, the United States views China as its principal competitor. With both nations releasing increasingly capable new models, solutions, and robotics, public trust in AI has diverged sharply between China and the U.S. A recent United Nations Development Program survey measuring confidence that AI systems are designed in society’s best interest found trust levels at 83 percent in China compared with just 38 percent in the U.S.

A recent United Nations Development Program survey measuring confidence that AI systems are designed in societys best interest found trust levels at 83 percent in China compared with just 38 percent in the U.S.

Experts are far more optimistic about AI than the general public. For example, Pew Research found that AI experts feel that “AI will have a very positive impact” on the United States over the next 20 years (56 percent vs. 17 percent). China’s high-trust environment could enable it to close the AI adoption gap more quickly and take the lead in global AI. Ultimately, the AI race will be won or lost by the country that succeeds in building genuine public trust in the technology.

The health sector’s uptake of technology remains uneven. Some partnerships, like that of NewYork-Presbyterian and Columbia, show the extraordinary transformation within reach. They developed an AI tool called EchoNext that accurately identified structural heart disease from electrocardiogram readings more frequently than cardiologists, flagging more than 7,500 high-risk patients in eight months. Meanwhile, at least 70 percent of healthcare providers still exchange medical information using a fax machine (according to Steve Posnack, deputy assistant coordinator in the Office of the National Coordinator for Health Information Technology). Many still are not able to access a complete patient record digitally. For modernization to truly take hold, and for adoption of AI to be systematic and widespread, we need greater confidence in its safety and effectiveness.

The precedent exists for our achieving that goal.  Indeed, in 1968, the U.S. National Highway Traffic Safety Administration (NHTSA) mandated seatbelts and introduced new crash safety standards. From 1968 through 2019, NHTSA’s safety standards prevented more than 860,000 deaths on the nation’s roads, 49 million nonfatal injuries, and damage to 65 million vehicles. Today, automakers now compete on safety features (see Volvo’s consistent seatbelt marketing). In the 1950s, air travel was perceived as dangerous, with a fatal accident rate of roughly 5 deaths per 100,000 flight hours. After the Federal Aviation Administration introduced stringent pilot training, mandatory black box monitoring, and advances in aircraft design, that rate has dropped to 0 deaths per 100,000 flight hours for scheduled service flights, with the U.S. National Airspace System now operating more than 45,000 commercial flights a day.

For modernization to truly take hold, and for adoption of AI to be systematic and widespread, we need greater confidence in its safety and effectiveness.

Other sectors have signaled that policy change to prioritize safety can and does restore trust and confidence in the marketplace, which in turn fuels adoption, drives competition, and accelerates growth. As U.S. Sen. Mike Rounds (R-SD) said at the top of a July 30 Senate Banking insurance subcommittee hearing, “we need regulatory frameworks that both support innovation and protect consumers.” Hard policy levers, in the form of regulation, legislation, and funding incentives, can support innovation in healthcare by investing in three essential building blocks:

1. Privacy-preserving data systems that let information stay local (e.g. in a health system) so that developers can securely access the right data;

2. Continuous monitoring to track safety, bias, and performance in real time so that failures or degradation can be corrected in real-time; and,

3. Public benchmarks and registries so AI tools can be tracked, compared, reproduced, and improved to raise quality and lower cost.

These investments would make it easier for innovators to develop safe, effective tools and for health systems to adopt them quickly, ensuring that people in rural, tribal, and urban communities alike can benefit from AI.

Building a clear, strong national infrastructure for AI in healthcare is not just about technological progress, it is about building trust, closing care gaps, and guaranteeing that every patient has access to tools that can improve care. As Senator Rounds noted, the AI Action Plan “recognizes the urgency to accelerate innovation, incentives to build AI infrastructure and lead in international diplomacy and security, all while acknowledging the need to address potential risks and promote trustworthy AI.”

The “move fast and break things” slogan that was coined by Mark Zuckerberg and is at the heart of AI development in Silicon Valley today is diametrically opposed to the credo of “do no harm” in healthcare.  Therefore, AI moves at the speed of trust. If the United States is to maintain global leadership, we need to radically prioritize transparency and trust because only then will we see meaningful adoption, better performance, and real-world impact for patients.

Lucy Orr-Ewing serves as Chief of Staff and Head of Policy for the Coalition for Health AI (CHAI), a nonprofit coalition dedicated to ensuring widespread development and deployment of Responsible AI in healthcare.